119 related articles for article (PubMed ID: 35879850)
1. Evolution of the Comprehensive Medication Review Completion Rate for Medicare Part D Plans: What Do the Stars Tell Us?
Cooke CE; Olshanskaya S; Lee M; Brandt NJ
Sr Care Pharm; 2022 Aug; 37(8):357-365. PubMed ID: 35879850
[No Abstract] [Full Text] [Related]
2. Evaluation of Comprehensive Medication Review Completion Rates Using 3 Patient Outreach Models.
Miller DE; Roane TE; Salo JA; Hardin HC
J Manag Care Spec Pharm; 2016 Jul; 22(7):796-800. PubMed ID: 27348280
[TBL] [Abstract][Full Text] [Related]
3. Improving Comprehensive Medication Review Acceptance by Using a Standardized Recruitment Script: A Randomized Control Trial.
Miguel A; Hall A; Liu W; Garrett J; Ballew A; Yang TH; Segal R
J Manag Care Spec Pharm; 2017 Jan; 23(1):13-21. PubMed ID: 28025924
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of an integrated adherence program aimed to increase Medicare Part D star rating measures.
Leslie RS; Tirado B; Patel BV; Rein PJ
J Manag Care Spec Pharm; 2014 Dec; 20(12):1193-203. PubMed ID: 25443513
[TBL] [Abstract][Full Text] [Related]
5. A Multichannel Medication Adherence Intervention Influences Patient and Prescriber Behavior.
Leslie RS; Gilmer T; Natarajan L; Hovell M
J Manag Care Spec Pharm; 2016 May; 22(5):526-38. PubMed ID: 27123914
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Medication Review Completion Rates and Disparities After Medicare Star Rating Measure.
Hung A; Wilson L; Smith VA; Pavon JM; Sloan CE; Hastings SN; Farley J; Maciejewski ML
JAMA Health Forum; 2024 May; 5(5):e240807. PubMed ID: 38700854
[TBL] [Abstract][Full Text] [Related]
7. Do comprehensive medication review completion rates predict medication use and management quality?
Wang Y; Farley JF; Ferreri SP; Renfro CP
Res Social Adm Pharm; 2019 Apr; 15(4):417-424. PubMed ID: 30917893
[TBL] [Abstract][Full Text] [Related]
8. Geographic Variation in the Prevalence of High-Risk Medication Use Among Medicare Part D Beneficiaries by Hospital Referral Region.
Chinthammit C; Bhattacharjee S; Axon DR; Slack M; Bentley JP; Warholak TL; Wilson DL; Lo-Ciganic WH
J Manag Care Spec Pharm; 2020 Oct; 26(10):1309-1316. PubMed ID: 32996396
[TBL] [Abstract][Full Text] [Related]
9. Is there an association between the high-risk medication star ratings and member experience CMS star ratings measures?
Erickson SC; Leslie RS; Patel BV
J Manag Care Spec Pharm; 2014 Nov; 20(11):1129-36. PubMed ID: 25351974
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Plan Type and Comprehensive Medication Reviews on High-Risk Medication Use.
Almodovar AS; Axon DR; Coleman AM; Warholak T; Nahata MC
J Manag Care Spec Pharm; 2018 May; 24(5):416-422. PubMed ID: 29694292
[TBL] [Abstract][Full Text] [Related]
11. Relationships between Medicare Advantage contract characteristics and quality-of-care ratings: an observational analysis of Medicare Advantage star ratings.
Xu P; Burgess JF; Cabral H; Soria-Saucedo R; Kazis LE
Ann Intern Med; 2015 Mar; 162(5):353-8. PubMed ID: 25732277
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Medication Reviews in Long-term Care Facilities: History of Process Implementation and 2015 Results.
O'Shea TE; Zarowitz BJ; Erwin WG
J Manag Care Spec Pharm; 2017 Jan; 23(1):22-26. PubMed ID: 28025922
[TBL] [Abstract][Full Text] [Related]
13. Adjusting Medicare Advantage star ratings for socioeconomic status and disability.
Sorbero ME; Paddock SM; Damberg CL; Haas A; Kommareddi M; Tolpadi A; Mathews M; Elliott MN
Am J Manag Care; 2018 Sep; 24(9):e285-e291. PubMed ID: 30222924
[TBL] [Abstract][Full Text] [Related]
14. Online Provision of Part D Medication Therapy Management Program Information.
Tong Z; Cooke CE; Brandt NJ
J Manag Care Spec Pharm; 2019 Aug; 25(8):898-903. PubMed ID: 31347982
[TBL] [Abstract][Full Text] [Related]
15. Association between Higher Generic Drug Use and Medicare Part D Star Ratings: An Observational Analysis.
Hohmann N; Hansen R; Garza KB; Harris I; Kiptanui Z; Qian J
Value Health; 2018 Oct; 21(10):1186-1191. PubMed ID: 30314619
[TBL] [Abstract][Full Text] [Related]
16. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
[TBL] [Abstract][Full Text] [Related]
17. A checklist for a consistent, comprehensive medication review.
Vaffis S; Dhatt H; Anderson E; Le D; Campbell PJ; Nelson M; Black H; Kolobova I; Axon DR; Warholak T
J Am Pharm Assoc (2003); 2023; 63(5):1504-1507.e1. PubMed ID: 37394060
[TBL] [Abstract][Full Text] [Related]
18. Quality of Home Health Agencies Serving Traditional Medicare vs Medicare Advantage Beneficiaries.
Schwartz ML; Kosar CM; Mroz TM; Kumar A; Rahman M
JAMA Netw Open; 2019 Sep; 2(9):e1910622. PubMed ID: 31483472
[TBL] [Abstract][Full Text] [Related]
19. The Star Rating System and Medicare Advantage Plans.
Sprague L
Issue Brief George Wash Univ Natl Health Policy Forum; 2015 May; (854):1-10. PubMed ID: 26072530
[TBL] [Abstract][Full Text] [Related]
20. A Pharmacist-Led, Patient-Centered Program Incorporating Motivational Interviewing for Behavior Change to Improve Adherence Rates and Star Ratings in a Medicare Plan.
Spears J; Erkens J; Misquitta C; Cutler T; Stebbins M
J Manag Care Spec Pharm; 2020 Jan; 26(1):35-41. PubMed ID: 31880222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
